Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions
October 19, 2022 08:00 ET
|
Certara
PRINCETON, N.J., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Certara, Inc., (Nasdaq: CERT) a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)...
Polyimide Films Market is projected to reach USD 3.0 Billion by 2030, growing at a CAGR of 5.9%: Straits Research
August 03, 2022 12:40 ET
|
Straits Research
New York, United States, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Polyimide Films are synthetic films that are frequently employed in applications subject to hostile conditions due to their operational...
Universe Pharmaceuticals INC Announces Strategic Alliance with Kitanihon Pharmaceutical Co., Ltd. to Address the Market Demand for Kampo Medicine and High-end Traditional Chinese Medicine
December 13, 2021 08:30 ET
|
Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on...
Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions
June 23, 2021 19:00 ET
|
Certara
PRINCETON, N.J., June 23, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has renewed its...
Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.
May 25, 2021 08:00 ET
|
Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, May 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the...
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
August 29, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
August 29, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
Corbus Pharmaceuticals Initiates “DETERMINE” Phase 3 Study in Dermatomyositis
December 17, 2018 07:00 ET
|
Corbus Pharmaceuticals Holdings, Inc.
DM is a rare systemic autoimmune disease that affects ~80,000 individuals in the U.S., EU and Japan and has a 5-year mortality rate as high as 30% This marks Company’s second Phase 3 program in rare...
Invivoscribe Submits the LeukoStrat CDx FLT3 Mutation Assay to Support Daiichi Sankyo Submission for Quizartinib in Japan
November 19, 2018 08:00 ET
|
Invivoscribe, Inc.
SAN DIEGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- In support of an ongoing partnership with Daiichi Sankyo, Invivoscribe is pleased to announce submission of the LeukoStrat® CDx FLT3 Mutation Assay to...
Japanska läkemedelsmyndigheten (PMDA) ger sitt stöd för en expansion av PledOx® fas III-program till att inkludera japanska patienter
June 13, 2018 02:30 ET
|
PledPharma AB
Stockholm, 13 juni 2018. PledPharma AB (publ) och deras partner Solasia Pharma K.K. (Solasia) meddelar idag att den japanska läkemedelsmyndigheten (PMDA) som följd av mötet med PledPharma och Solasia,...